MedPath

IgG-mediated Food Test for Weight Loss

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Other: Replace reactive foods with non-reactive foods
Registration Number
NCT01592071
Lead Sponsor
University of Miami
Brief Summary

This study assessed the effect of an IgG-mediated food sensitivity test in combination with a food elimination diet on body composition and secondary outcomes in people who were overweight.

Detailed Description

This study looked at foods that stimulated IgG food antibody production, which may play a role in certain conditions, such as irritable bowel syndrome, obesity, type I diabetes, and migraine headaches.

Using a proprietary blood test, the Immuno Bloodprint, to determine which foods stimulate IgG food antibodies in each person, this study detailed a personalized list of reactive foods that stimulated such antibodies for each participant. The participant was then advised to eliminate as much as possible the reactive foods for 90 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • BMI above 20
  • Express an interest in losing weight
Exclusion Criteria
  • Less than 18 years of age
  • Currently participating in another research trial for weight loss
  • Suffering from serious medical complications that might limit their participation, such as recent heart attack, stroke, or chronic kidney disease
  • Pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Replace reactive w/ non-reactive foodsReplace reactive foods with non-reactive foodsTest results, individual dietary plan: 'Replace reactive foods with non-reactive foods'
Primary Outcome Measures
NameTimeMethod
Body Mass Index30, 60 and 90 days from baseline

Measure of body composition: height and weight to assess BMI.

Waist Circumference30, 60 and 90 days from baseline

Measure of body composition: waist circumference (cm).

Hip Circumference30, 60 or 90 days from baseline

Measure of body composition: hip circumference (cm).

Weight (kg)30, 60 and 90 days from baseline

Measure of body composition: weight (kg).

Waist-Hip Ratio (WHR)30, 60 or 90 days from baseline

Measure of body composition: hip and waist circumference to calculate waist/hip ratio (WHR).

Secondary Outcome Measures
NameTimeMethod
Blood Pressure30, 60 and 90 days from baseline

Systolic and diastolic blood pressure measured.

Heart Rate30, 60 and 90 days from baseline

Heart rate measured.

Quality of Life30, 60 or 90 days from baseline

Quality of life categories measured with the SF-36 Health Survey. The SF-36 Health Survey provides psychometrically-based physical and mental health summary measures and a preference-based health utility index.The SF-36 provides a t-score for each scale or domain ranging from 0-100 with higher scores representing better perceived quality of life.

Trial Locations

Locations (1)

University of Miami CRB

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath